RAB5A and neoplasm: For example, biomarkers such as circulating tumor DNA (ctDNA) levels, SLC46A3 transporter status, and Ras-related protein Rab-5A (RAB5A) expression - an endocytic trafficking regulator from the RAS oncogene family - are under investigation.